Raymond James Financial
DXCM icon

Raymond James Financial’s DexCom DXCM Stock Holding History

Raymond James Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Hold
5,000
– – ﹤0.01% 4819
2026
Q1 		$300K Buy
+5,000
New +$348K ﹤0.01% 4655

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Raymond James Financial's DXCM Position: Q2 2026 in Review

Raymond James Financial increased its DexCom (DXCM) stake by 11% in Q2 2026, buying an estimated $20.3M and bringing the position to 3,087,990 shares worth $208M. The position accounts for 0.06% of the portfolio, ranked #302.

Raymond James Financial first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $295M in Q2 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Raymond James Financial held 3,087,990 shares of DexCom worth $208M as of Q2 2026.
  • Raymond James Financial bought 305,363 DexCom shares in Q2 2026, an estimated $20.3M.
  • DexCom made up 0.06% of Raymond James Financial's portfolio in Q2 2026, its #302 holding.
  • Raymond James Financial first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's DexCom position peaked at $295M in Q2 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.